Genome Editing: Insights from Chemical Biology to Support Safe and Transformative Therapeutic Applications

Programmable nuclease-based genome editing technologies, including the clustered, regularly interspaced, short palindromic repeats (CRISPR)/Cas9 system, are becoming an essential component of many applications ranging from agriculture to medicine. However, fundamental limitations currently prevent t...

Full description

Saved in:
Bibliographic Details
Published in:ACS chemical biology Vol. 13; no. 2; pp. 333 - 342
Main Authors: Wegrzyn, Renee D, Lee, Andrew H, Jenkins, Amy L, Stoddard, Colby D, Cheever, Anne E
Format: Journal Article
Language:English
Published: United States American Chemical Society 16-02-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Programmable nuclease-based genome editing technologies, including the clustered, regularly interspaced, short palindromic repeats (CRISPR)/Cas9 system, are becoming an essential component of many applications ranging from agriculture to medicine. However, fundamental limitations currently prevent the widespread, safe, and practical use of genome editors, especially for human disease interventions. These limitations include off-target effects, a lack of control over editing activity, suboptimal DNA repair outcomes, insufficient target conversion, and inadequate delivery performance. This perspective focuses on the potential for biological chemistry to address these limitations such that newly developed genome editing technologies can enable the broadest range of potential future applications. Equally important will be the development of these powerful technologies within a relevant ethical framework that emphasizes safety and responsible innovation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1554-8929
1554-8937
DOI:10.1021/acschembio.7b00689